Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: 148-reexam: Non-Final Action Mailed on 12-21-2007
Thanks for that heads up.  I take it you are saying then that if the initial office action was a rejection, it would say so.  Correct.  Thanks again for all you do to keep us well informed.    Opty
Share
New Message
Please login to post a reply